{"id":27719,"date":"2021-11-30T09:24:40","date_gmt":"2021-11-30T08:24:40","guid":{"rendered":"https:\/\/kymos.com\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/"},"modified":"2021-11-30T09:24:40","modified_gmt":"2021-11-30T08:24:40","slug":"kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique","status":"publish","type":"post","link":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/","title":{"rendered":"Kymos et ISGlobal unissent leurs efforts pour mettre fin aux maladies parasitaires en Afrique"},"content":{"rendered":"<p><span style=\"font-size: 14pt;\">\u00ab Kymos est un groupe qui applique les normes \u00e9thiques les plus strictes. Il ne s\u2019agit pas d\u2019un simple communiqu\u00e9 de presse, mais bien de notre philosophie au quotidien \u00bb, souligne le Dr Carles Celma, directeur scientifique de Kymos. \u00ab Nous avons \u00e9t\u00e9 ravis de nous impliquer activement dans le projet STOP pour le traitement des parasites intestinaux dans les pays en d\u00e9veloppement d\u00e8s que ISGlobal nous a contact\u00e9s. \u00bb  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">L\u2019Institut de Barcelone pour la sant\u00e9 mondiale (ISGlobal) est un partenariat public-priv\u00e9 qui s\u2019engage \u00e0 r\u00e9duire les in\u00e9galit\u00e9s de sant\u00e9 entre les r\u00e9gions du monde. L\u2019Institut pilote des projets tels que STOP (Stopping Transmission in intestinal Parasites), financ\u00e9 par l\u2019EDCTP, qui vise \u00e0 tester une nouvelle coformulation m\u00e9dicamenteuse contre les maladies parasitaires. Le Dr Jos\u00e9 Mu\u00f1oz, chercheur principal, explique le p\u00e9rim\u00e8tre du projet STOP&nbsp;:  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">\u00ab&nbsp;Les vers parasites vivent dans l\u2019intestin de pr\u00e8s d\u2019un cinqui\u00e8me de la population mondiale et constituent une cause majeure de malnutrition, de retard de croissance et d\u2019an\u00e9mie chez l\u2019enfant&nbsp;\u00bb, explique le Dr Mu\u00f1oz. \u00ab&nbsp;Les traitements actuels sont inefficaces contre la trichoc\u00e9phalose et l\u2019oxyurose, et l\u2019Organisation mondiale de la Sant\u00e9 recommande la mise en \u0153uvre urgente de l\u2019ivermectine et de l\u2019albendazole comme alternative prometteuse. Nous pr\u00e9voyons d\u2019inclure et de traiter 1&nbsp;223 enfants dans le cadre d\u2019essais cliniques men\u00e9s au Kenya, au Mozambique et en \u00c9thiopie, trois pays africains pr\u00e9sentant une pr\u00e9valence mod\u00e9r\u00e9e \u00e0 \u00e9lev\u00e9e de ces maladies parasitaires.&nbsp;\u00bb  <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Mais aussi passionnant qu&rsquo;un tel projet puisse \u00eatre, il n&rsquo;\u00e9tait pas sans difficult\u00e9s. Carles Celma se souvient des probl\u00e8mes initiaux rencontr\u00e9s&nbsp;: \u00ab&nbsp;ISGlobal nous a sollicit\u00e9s pour quantifier l&rsquo;ivermectine et l&rsquo;albendazole dans des \u00e9tudes cliniques de phase II-III, dans des circonstances exceptionnelles&nbsp;: afin de pr\u00e9server la cha\u00eene du froid lors du pr\u00e9l\u00e8vement des \u00e9chantillons sur les trois sites cliniques, il a fallu utiliser les capsules de micro-\u00e9chantillonnage MITRA, une technologie qui exige le d\u00e9veloppement de m\u00e9thodes analytiques expertes. Je suis fier de dire que nous avons r\u00e9ussi \u00e0 accompagner ISGlobal de la meilleure fa\u00e7on possible&nbsp;\u00bb, conclut le Dr&nbsp;Celma avec satisfaction. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Jos\u00e9 Mu\u00f1oz compl\u00e8te les propos de Carles Celma&nbsp;: \u00ab&nbsp;Nous sommes tr\u00e8s satisfaits de Kymos. En fait, c\u2019est le fabricant m\u00eame de l\u2019ivermectine et de l\u2019albendazole qui nous a recommand\u00e9 de confier \u00e0 Kymos la partie analytique de notre projet&nbsp;: Jaime Algorta d\u2019Exeltis poss\u00e8de une longue et fructueuse exp\u00e9rience avec Kymos et a exprim\u00e9 (je cite) un vif int\u00e9r\u00eat pour leur participation en raison de leur fiabilit\u00e9.&nbsp;\u00bb<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Le Dr Celma conclut l&rsquo;entretien sur une note diff\u00e9rente&nbsp;: \u00ab&nbsp;Nous sommes naturellement ravis de recevoir ce type de reconnaissance pour notre travail, mais savoir que, gr\u00e2ce \u00e0 notre contribution, nous luttons contre les infestations parasitaires, contribuons \u00e0 briser le cycle de la pauvret\u00e9 et permettons \u00e0 ces enfants d&rsquo;aller \u00e0 l&rsquo;\u00e9cole et de subvenir aux besoins de leur famille, voil\u00e0 ce qui rend notre collaboration avec ISGlobal v\u00e9ritablement exceptionnelle. C&rsquo;est ainsi que nous savons que nous sommes dans le bon domaine&nbsp;\u00bb, conclut-il.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size: 14pt;\">L\u2019Institut de Barcelone pour la sant\u00e9 mondiale (ISGlobal) est n\u00e9 d\u2019une alliance novatrice entre la Fondation \u00ab&nbsp;la Caixa&nbsp;\u00bb, des institutions acad\u00e9miques et des organismes gouvernementaux, afin de contribuer aux efforts d\u00e9ploy\u00e9s par la communaut\u00e9 internationale pour relever les d\u00e9fis de la sant\u00e9 mondiale. Cliquez ici pour en savoir plus sur <a href=\"https:\/\/www.isglobal.org\/en\" data-wpel-link=\"external\"><strong>ISGlobal<\/strong><\/a> ou le projet <a href=\"https:\/\/stoptheworm.org\/\" data-wpel-link=\"external\"><strong>STOP<\/strong><\/a> , ou contactez-nous \u00e0 l\u2019 <a href=\"mailto:info@isglobal.org?subject=Kymos%20and%20ISGlobal%20join%20efforts%20to%20STOP%20parasitic%20diseases%20in%20Africa\" data-wpel-link=\"internal\"><strong>adresse info@isglobal.org<\/strong><\/a> . <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00ab Kymos est un groupe qui applique les normes \u00e9thiques  [&#8230;]<\/p>\n","protected":false},"author":6,"featured_media":27724,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[260,258],"tags":[62],"class_list":["post-27719","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-groupe-kymos","category-nouvelles","tag-joan"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enrayer les maladies parasitaires en Afrique | Groupe Kymos<\/title>\n<meta name=\"description\" content=\"Kymos, une CRO sp\u00e9cialis\u00e9e dans les services de bioanalyse et de CMC pour les petites mol\u00e9cules, les produits biologiques et les acides nucl\u00e9iques, soutient ISGlobal dans le cadre du projet STOP.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enrayer les maladies parasitaires en Afrique | Groupe Kymos\" \/>\n<meta property=\"og:description\" content=\"Kymos, une CRO sp\u00e9cialis\u00e9e dans les services de bioanalyse et de CMC pour les petites mol\u00e9cules, les produits biologiques et les acides nucl\u00e9iques, soutient ISGlobal dans le cadre du projet STOP.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/\" \/>\n<meta property=\"og:site_name\" content=\"Kymos\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-30T08:24:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1456\" \/>\n\t<meta property=\"og:image:height\" content=\"806\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Joan Puig de Dou\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:site\" content=\"@KymosGroup\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joan Puig de Dou\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/\"},\"author\":{\"name\":\"Joan Puig de Dou\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"headline\":\"Kymos et ISGlobal unissent leurs efforts pour mettre fin aux maladies parasitaires en Afrique\",\"datePublished\":\"2021-11-30T08:24:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/\"},\"wordCount\":643,\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"keywords\":[\"joan\"],\"articleSection\":[\"Kymos Group\",\"Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/\",\"url\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/\",\"name\":\"Enrayer les maladies parasitaires en Afrique | Groupe Kymos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"datePublished\":\"2021-11-30T08:24:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\"},\"description\":\"Kymos, une CRO sp\u00e9cialis\u00e9e dans les services de bioanalyse et de CMC pour les petites mol\u00e9cules, les produits biologiques et les acides nucl\u00e9iques, soutient ISGlobal dans le cadre du projet STOP.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"contentUrl\":\"https:\\\/\\\/kymos.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/21-11-25_STOP_Newsletter_Banner_short_small.png\",\"width\":1456,\"height\":806,\"caption\":\"IS Global STOP\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kymos.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kymos et ISGlobal unissent leurs efforts pour mettre fin aux maladies parasitaires en Afrique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/kymos.com\\\/fr\\\/\",\"name\":\"Kymos Group\",\"description\":\"Kymos Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kymos.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kymos.com\\\/fr\\\/#\\\/schema\\\/person\\\/264c93ce9dcf43caa9d634aeafab965c\",\"name\":\"Joan Puig de Dou\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g\",\"caption\":\"Joan Puig de Dou\"},\"description\":\"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.\",\"url\":\"https:\\\/\\\/kymos.com\\\/fr\\\/news\\\/author\\\/joan-puig-de-dou\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enrayer les maladies parasitaires en Afrique | Groupe Kymos","description":"Kymos, une CRO sp\u00e9cialis\u00e9e dans les services de bioanalyse et de CMC pour les petites mol\u00e9cules, les produits biologiques et les acides nucl\u00e9iques, soutient ISGlobal dans le cadre du projet STOP.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/","og_locale":"fr_FR","og_type":"article","og_title":"Enrayer les maladies parasitaires en Afrique | Groupe Kymos","og_description":"Kymos, une CRO sp\u00e9cialis\u00e9e dans les services de bioanalyse et de CMC pour les petites mol\u00e9cules, les produits biologiques et les acides nucl\u00e9iques, soutient ISGlobal dans le cadre du projet STOP.","og_url":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/","og_site_name":"Kymos","article_published_time":"2021-11-30T08:24:40+00:00","og_image":[{"width":1456,"height":806,"url":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","type":"image\/png"}],"author":"Joan Puig de Dou","twitter_card":"summary_large_image","twitter_creator":"@KymosGroup","twitter_site":"@KymosGroup","twitter_misc":{"\u00c9crit par":"Joan Puig de Dou","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#article","isPartOf":{"@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/"},"author":{"name":"Joan Puig de Dou","@id":"https:\/\/kymos.com\/fr\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"headline":"Kymos et ISGlobal unissent leurs efforts pour mettre fin aux maladies parasitaires en Afrique","datePublished":"2021-11-30T08:24:40+00:00","mainEntityOfPage":{"@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/"},"wordCount":643,"image":{"@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","keywords":["joan"],"articleSection":["Kymos Group","Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/","url":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/","name":"Enrayer les maladies parasitaires en Afrique | Groupe Kymos","isPartOf":{"@id":"https:\/\/kymos.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#primaryimage"},"image":{"@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#primaryimage"},"thumbnailUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","datePublished":"2021-11-30T08:24:40+00:00","author":{"@id":"https:\/\/kymos.com\/fr\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c"},"description":"Kymos, une CRO sp\u00e9cialis\u00e9e dans les services de bioanalyse et de CMC pour les petites mol\u00e9cules, les produits biologiques et les acides nucl\u00e9iques, soutient ISGlobal dans le cadre du projet STOP.","breadcrumb":{"@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#primaryimage","url":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","contentUrl":"https:\/\/kymos.com\/wp-content\/uploads\/2021\/11\/21-11-25_STOP_Newsletter_Banner_short_small.png","width":1456,"height":806,"caption":"IS Global STOP"},{"@type":"BreadcrumbList","@id":"https:\/\/kymos.com\/fr\/news\/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kymos.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Kymos et ISGlobal unissent leurs efforts pour mettre fin aux maladies parasitaires en Afrique"}]},{"@type":"WebSite","@id":"https:\/\/kymos.com\/fr\/#website","url":"https:\/\/kymos.com\/fr\/","name":"Kymos Group","description":"Kymos Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kymos.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/kymos.com\/fr\/#\/schema\/person\/264c93ce9dcf43caa9d634aeafab965c","name":"Joan Puig de Dou","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/263d7ff1c7891f5821a5075a1a362a1e513db5931dc882455e887fe1c1ccf924?s=96&d=mm&r=g","caption":"Joan Puig de Dou"},"description":"Active in the pharmaceutical marketing for over 30 years President of CataloniaBIO&amp;HealthTech CEO and Qualified Person at Kymos Leader of Kymos team, guaranteeing a trustable, ethical and scientific correct editorial publications. Experience Joan Puig de Dou started his career at Laboratorios Menarini first as scientist later as Qualified Person and finally as Operations General Manager. 2010 he entered Kymos where he became CEO in 2015. 2022 Joan Puig de Dou was elected as president of CataloniaBio&amp;HealthTech to represent the Catalonian biotech industry nationally and internationally. Expertise Joan Puig de Dou has extensive experience in writing scientific content adopting a didactic approach that fits any reader\u2019s level of expertise. He publishes regularely on Kymos\u2019 webpage, social media and in the specialized press. Education He graduated from Universitat de Barcelona as Pharmacist and from IESE Business School\u2019s Programa Diecci\u00f3n General (PDG) Want to know him better? Read his interview in PharmaBoardrooom in January 2019 and more about his presidency of CataloniaBio at Parc Sc\u00edentific de Barcelona.","url":"https:\/\/kymos.com\/fr\/news\/author\/joan-puig-de-dou\/"}]}},"_links":{"self":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/posts\/27719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/comments?post=27719"}],"version-history":[{"count":0,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/posts\/27719\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/media\/27724"}],"wp:attachment":[{"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/media?parent=27719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/categories?post=27719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kymos.com\/fr\/wp-json\/wp\/v2\/tags?post=27719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}